FIM study

We have succesfully finished our first First in Man study with psychoactive, anti-depressive substance, which is expected to be a breakthrough in depression treatment.

The study is conducted for one of the most promising Polish phramaceutical companies,  as a part of NCBiR programme.

Go back

News

TransCelerate accreditation

To improve our trainings system, we joined „GCP Mutual Recognition Program" and were accredited by TransCelerate Biopharma Inc

Read more …

Happy Easter!

To all our employees, co-workers, clients and patients we would like to express our best wishes of joyful and peaceful Easter.

Read more …

Pediatrics Clinical Trials - conference

On 16th of April, 2019 we attended an interesting conference concerning clinical trials in pediatrics organised by GCPpl society.

Read more …

Personal Data Security in Clinical Trials

On 21st of March, 2019 our representatives attended workshops concerning personal data security in clinical trials.

Read more …

GCLP accreditation

We are proud to announce that on February 2019 we have received a GCLP certificate which confirms our high quality of services.

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2022 © Bio Research Group. All rights reserved.

 

scroll to top ▲